• Je něco špatně v tomto záznamu ?

High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges

AW. Langerak, M. Brüggemann, F. Davi, N. Darzentas, JJM. van Dongen, D. Gonzalez, G. Cazzaniga, V. Giudicelli, MP. Lefranc, M. Giraud, EA. Macintyre, M. Hummel, C. Pott, PJTA. Groenen, K. Stamatopoulos, . ,

. 2017 ; 198 (10) : 3765-3774. [pub] 20170417

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17030880

Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage, and biases. With the advent of high-throughput, next-generation sequencing (NGS) technologies, a deeper analysis of Ig and/or TCR (IG/TR) gene rearrangements is now within reach, which impacts on all main applications of IG/TR immunogenetic analysis. To bridge the generation gap from low- to high-throughput analysis, the EuroClonality-NGS Consortium has been formed, with the main objectives to develop, standardize, and validate the entire workflow of IG/TR NGS assays for 1) clonality assessment, 2) minimal residual disease detection, and 3) repertoire analysis. This concerns the preanalytical (sample preparation, target choice), analytical (amplification, NGS), and postanalytical (immunoinformatics) phases. Here we critically discuss pitfalls and challenges of IG/TR NGS methodology and its applications in hemato-oncology and immunology.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17030880
003      
CZ-PrNML
005      
20171025122757.0
007      
ta
008      
171025s2017 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.4049/jimmunol.1602050 $2 doi
035    __
$a (PubMed)28416603
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Langerak, Anton W $u Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center, 3015 CN Rotterdam, the Netherlands; a.langerak@erasmusmc.nl.
245    10
$a High-Throughput Immunogenetics for Clinical and Research Applications in Immunohematology: Potential and Challenges / $c AW. Langerak, M. Brüggemann, F. Davi, N. Darzentas, JJM. van Dongen, D. Gonzalez, G. Cazzaniga, V. Giudicelli, MP. Lefranc, M. Giraud, EA. Macintyre, M. Hummel, C. Pott, PJTA. Groenen, K. Stamatopoulos, . ,
520    9_
$a Analysis and interpretation of Ig and TCR gene rearrangements in the conventional, low-throughput way have their limitations in terms of resolution, coverage, and biases. With the advent of high-throughput, next-generation sequencing (NGS) technologies, a deeper analysis of Ig and/or TCR (IG/TR) gene rearrangements is now within reach, which impacts on all main applications of IG/TR immunogenetic analysis. To bridge the generation gap from low- to high-throughput analysis, the EuroClonality-NGS Consortium has been formed, with the main objectives to develop, standardize, and validate the entire workflow of IG/TR NGS assays for 1) clonality assessment, 2) minimal residual disease detection, and 3) repertoire analysis. This concerns the preanalytical (sample preparation, target choice), analytical (amplification, NGS), and postanalytical (immunoinformatics) phases. Here we critically discuss pitfalls and challenges of IG/TR NGS methodology and its applications in hemato-oncology and immunology.
650    _2
$a alely $7 D000483
650    _2
$a výpočetní biologie $x metody $7 D019295
650    _2
$a genová přestavba $7 D015321
650    _2
$a geny pro imunoglobuliny $7 D005803
650    _2
$a geny TcR $x genetika $7 D019672
650    _2
$a hematologie $x metody $7 D006405
650    12
$a vysoce účinné nukleotidové sekvenování $x metody $7 D059014
650    _2
$a lidé $7 D006801
650    _2
$a imunogenetika $x metody $x normy $7 D007125
650    12
$a imunologické techniky $7 D007158
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brüggemann, Monika $u Second Medical Department, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
700    1_
$a Davi, Frédéric $u Département d'Hématologie, Assistance Publique - Hôpitaux de Paris Hopital Pitié-Salpêtrière and Université Pierre et Marie Curie - Université Paris IV, 75005 Paris, France.
700    1_
$a Darzentas, Nikos $u Molecular Medicine Program, Central European Institute of Technology, Masaryk University, 625 00 Brno, Czech Republic.
700    1_
$a van Dongen, Jacques J M $u Department of Immunology, Laboratory for Medical Immunology, Erasmus MC, University Medical Center, 3015 CN Rotterdam, the Netherlands; a.langerak@erasmusmc.nl.
700    1_
$a Gonzalez, David $u Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast BT9 7AE, United Kingdom.
700    1_
$a Cazzaniga, Gianni $u Centro Ricerca Tettamanti, Clinica Pediatrica Università Milano-Bicocca, 20900 Monza, Italy.
700    1_
$a Giudicelli, Véronique $u UMR 9002 CNRS - Université de Montpellier, 34396 Montpellier, France.
700    1_
$a Lefranc, Marie-Paule $u UMR 9002 CNRS - Université de Montpellier, 34396 Montpellier, France.
700    1_
$a Giraud, Mathieu $u Centre de Recherche en Informatique Signal et Automatique de Lille, CNRS, Université de Lille, 59000 Lille, France.
700    1_
$a Macintyre, Elizabeth A $u Département d'Hématologie, Assistance Publique - Hôpitaux de Paris Necker-Enfants Malades and Paris Descartes, 75015 Paris, France.
700    1_
$a Hummel, Michael $u Institut für Pathologie, Charité - Universitätsmedizin Berlin, D-10117 Berlin, Germany.
700    1_
$a Pott, Christiane $u Second Medical Department, University Hospital Schleswig-Holstein, 24105 Kiel, Germany.
700    1_
$a Groenen, Patricia J T A $u Department of Pathology, Radboud University Nijmegen Medical Center, 6525 GA Nijmegen, the Netherlands; and.
700    1_
$a Stamatopoulos, Kostas $u Institute of Applied Biosciences, Center for Research and Technology Hellas, GR-57001 Thessaloniki, Greece.
700    1_
$a ,
773    0_
$w MED00002741 $t Journal of immunology (Baltimore, Md. 1950) $x 1550-6606 $g Roč. 198, č. 10 (2017), s. 3765-3774
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28416603 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025122839 $b ABA008
999    __
$a ok $b bmc $g 1254473 $s 991907
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 198 $c 10 $d 3765-3774 $e 20170417 $i 1550-6606 $m The Journal of immunology $n J Immunol $x MED00002741
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace